{"id":382589,"date":"2020-11-17T06:03:18","date_gmt":"2020-11-17T11:03:18","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=382589"},"modified":"2020-11-17T06:03:18","modified_gmt":"2020-11-17T11:03:18","slug":"itamar-medical-reports-record-third-quarter-2020-revenues","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/itamar-medical-reports-record-third-quarter-2020-revenues\/","title":{"rendered":"Itamar Medical Reports Record Third Quarter 2020 Revenues"},"content":{"rendered":"
\n

\n
\n – <\/em>
\n <\/strong>
\n
\n Third <\/em>
\n <\/strong>
\n
\n Quarter<\/em>
\n <\/strong>
\n
\n Revenues Increase <\/em>
\n <\/strong>
\n
\n 36<\/em>
\n <\/strong>
\n
\n % <\/em>
\n <\/strong>
\n
\n to <\/em>
\n <\/strong>
\n
\n $<\/em>
\n <\/strong>
\n
\n 11.0<\/em>
\n <\/strong>
\n
\n Million –<\/em>
\n <\/strong>
\n \n <\/p>\n

\n
\n – <\/em>
\n <\/strong>
\n
\n U.S. <\/em>
\n <\/strong>
\n
\n WatchPAT<\/em>
\n <\/strong>
\n
\n
\n TM<\/em>
\n <\/strong>
\n <\/sup>
\n
\n Revenues Increase <\/em>
\n <\/strong>
\n
\n 55<\/em>
\n <\/strong>
\n
\n % <\/em>
\n <\/strong>
\n
\n t<\/em>
\n <\/strong>
\n
\n o <\/em>
\n <\/strong>
\n
\n $<\/em>
\n <\/strong>
\n
\n 8.9<\/em>
\n <\/strong>
\n
\n M<\/em>
\n <\/strong>
\n
\n illion<\/em>
\n <\/strong>
\n
\n \u2013<\/em>
\n <\/strong>\n <\/p>\n

\n
\n -Full Year 2020 Revenue Guidance of $39.5<\/em>
\n <\/strong>
\n
\n Million<\/em>
\n <\/strong>
\n
\n to $40.5<\/em>
\n <\/strong>
\n
\n Million<\/em>
\n <\/strong>
\n
\n –<\/em>
\n <\/strong>\n <\/p>\n

\n
\n – Company to Host Conference Call Today at 8:00<\/em>
\n <\/strong>
\n
\n am ET, 3:00<\/em>
\n <\/strong>
\n
\n pm IT – <\/em>
\n <\/strong>\n <\/p>\n

CAESAREA, Israel, Nov. 17, 2020 (GLOBE NEWSWIRE) — \u00a0Itamar Medical Ltd. (Nasdaq and TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders, today reported unaudited financial results for the third quarter of 2020.<\/p>\n

\u201cWe are very encouraged by our third quarter performance, driven by the persisting shift to home-based care with our WatchPAT ONE fully disposable product leading the growth. In fact, roughly 46% of the 500 sleep medicine practice members responding to a recent American Academy of Sleep Medicine survey are concerned about remaining financially solvent through the end of the year due to the impact of the coronavirus. We continue to see strong demand in the United States across almost all geographies and verticals led by cardiology and VA as well as key markets in Europe and Asia, with the one exception of U.S. dental volumes which are still lagging behind,\u201d said Gilad Glick, President and Chief Executive Officer of Itamar Medical.<\/p>\n

\u201cAs we approach year end, we are pleased with our progress on product innovation and market access programs, and we are looking forward to further reducing the barriers sleep apnea patients face in the coming years,\u201d concluded Glick.<\/p>\n

\n Third <\/strong>
\n Quarter <\/strong>
\n 2020 <\/strong>
\n Highlights<\/strong>
\n and <\/strong>
\n Full Year 2020 Revenue Guidance<\/strong>\n <\/p>\n